Literature DB >> 25127094

Rhabdoid differentiation is associated with aggressive behavior in renal cell carcinoma: a clinicopathologic analysis of 76 cases with clinical follow-up.

Christopher G Przybycin1, Jesse K McKenney, Jordan P Reynolds, Steven Campbell, Ming Zhou, Matthew T Karafa, Cristina Magi-Galluzzi.   

Abstract

Rhabdoid differentiation has been associated with aggressive behavior in carcinomas from different organ systems. A recent consensus statement of the International Society of Urological Pathology (ISUP), in addition to proposing a nucleolar grading system (ISUP grade) for renal cell carcinoma (RCC) to replace the Fuhrman system, recommended reporting the presence of rhabdoid differentiation in RCC and considering tumors with rhabdoid differentiation to be ISUP grade 4. Although it has been shown that rhabdoid differentiation is associated with increased grade and stage of RCC, it has not been fully demonstrated whether it has an adverse effect independent of this association with increased grade and stage. We provide the largest clinicopathologic analysis of RCC with rhabdoid differentiation to date (76 cases), including characterization of metastatic disease. In addition, by constructing a multivariable model including tumor grade, stage, necrosis, and distant metastasis to compare a series of 49 clear cell RCC with rhabdoid differentiation with a cohort of 41 clear cell RCCs without rhabdoid differentiation, we demonstrate that the presence of rhabdoid differentiation in clear cell RCC confers an increased risk of death (hazard ratio=5.25; 95% confidence interval, 2.1-14.3) independent of these other adverse prognostic factors. These findings underscore the significance of rhabdoid differentiation in RCC as an adverse prognostic factor and support the recent reporting and grading recommendations of the ISUP.

Entities:  

Mesh:

Year:  2014        PMID: 25127094     DOI: 10.1097/PAS.0000000000000251

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  17 in total

1.  Sporadic renal hemangioblastoma with CA9, PAX2 and PAX8 expression: diagnostic pitfall in the differential diagnosis from clear cell renal cell carcinoma.

Authors:  Naoto Kuroda; Yoshiko Agatsuma; Masato Tamura; Petr Martinek; Ondrej Hes; Michal Michal
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

Review 2.  Percutaneous biopsy for risk stratification of renal masses.

Authors:  Michael L Blute; Anna Drewry; Edwin Jason Abel
Journal:  Ther Adv Urol       Date:  2015-10

3.  Novel K6-K14 keratin fusion enhances cancer stemness and aggressiveness in oral squamous cell carcinoma.

Authors:  Fuu-Jen Tsai; Ming-Tsung Lai; Jack Cheng; Stev Chun-Chin Chao; Praveen Kumar Korla; Hui-Jye Chen; Chung-Ming Lin; Ming-Hsui Tsai; Chun-Hung Hua; Chia-Ing Jan; Natini Jinawath; Chia-Chen Wu; Chih-Mei Chen; Brian Yu-Ting Kuo; Li-Wen Chen; Jacky Yang; Tritium Hwang; Jim Jinn-Chyuan Sheu
Journal:  Oncogene       Date:  2019-03-13       Impact factor: 9.867

4.  Renal cell carcinoma with rhabdoid-like features lack intracytoplasmic inclusion bodies and show aggressive behavior.

Authors:  Masaaki Sugimoto; Kenichi Kohashi; Kentaro Kuroiwa; Tatsuro Abe; Yuichi Yamada; Masaki Shiota; Kenjiro Imada; Seiji Naito; Yoshinao Oda
Journal:  Virchows Arch       Date:  2015-12-09       Impact factor: 4.064

5.  Prognostic implications of sarcomatoid and rhabdoid differentiation in patients with grade 4 renal cell carcinoma.

Authors:  Onder Kara; Matthew J Maurice; Homayoun Zargar; Ercan Malkoc; Oktay Akca; Hiury S Andrade; Daniel Ramirez; Peter A Caputo; Ryan J Nelson; Brian Rini; Jihad H Kaouk
Journal:  Int Urol Nephrol       Date:  2016-05-23       Impact factor: 2.370

6.  Comprehensive evaluation of 68Ga-PSMA-11 PET/CT parameters for discriminating pathological characteristics in primary clear-cell renal cell carcinoma.

Authors:  Jie Gao; Qinfeng Xu; Yao Fu; Kuiqiang He; Chengwei Zhang; Qing Zhang; Jiong Shi; Xiaozhi Zhao; Feng Wang; Hongqian Guo
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-07-04       Impact factor: 9.236

7.  New developments in existing WHO entities and evolving molecular concepts: The Genitourinary Pathology Society (GUPS) update on renal neoplasia.

Authors:  Kiril Trpkov; Ondrej Hes; Sean R Williamson; Anthony J Gill; Adebowale J Adeniran; Abbas Agaimy; Reza Alaghehbandan; Mahul B Amin; Pedram Argani; Ying-Bei Chen; Liang Cheng; Jonathan I Epstein; John C Cheville; Eva Comperat; Isabela Werneck da Cunha; Jennifer B Gordetsky; Sounak Gupta; Huiying He; Michelle S Hirsch; Peter A Humphrey; Payal Kapur; Fumiyoshi Kojima; Jose I Lopez; Fiona Maclean; Cristina Magi-Galluzzi; Jesse K McKenney; Rohit Mehra; Santosh Menon; George J Netto; Christopher G Przybycin; Priya Rao; Qiu Rao; Victor E Reuter; Rola M Saleeb; Rajal B Shah; Steven C Smith; Satish Tickoo; Maria S Tretiakova; Lawrence True; Virginie Verkarre; Sara E Wobker; Ming Zhou
Journal:  Mod Pathol       Date:  2021-03-04       Impact factor: 8.209

8.  Intratumoral morphologic and molecular heterogeneity of rhabdoid renal cell carcinoma: challenges for personalized therapy.

Authors:  Rajesh R Singh; Paari Murugan; Lalit R Patel; Horatiu Voicu; Suk-Young Yoo; Tadeusz Majewski; Meenakshi Mehrotra; Khalida Wani; Nizar Tannir; Jose A Karam; Eric Jonasch; Christopher G Wood; Chad J Creighton; L Jeffrey Medeiros; Russell R Broaddus; Pheroze Tamboli; Keith A Baggerly; Kenneth D Aldape; Bogdan Czerniak; Rajyalakshmi Luthra; Kanishka Sircar
Journal:  Mod Pathol       Date:  2015-06-26       Impact factor: 7.842

9.  Malignant rhabdoid tumor in the renal allograft of an adult transplant recipient: a unique case of a rare tumor.

Authors:  Jing Xiong; Tiefen Su; Pengcheng Zhu; Qilin Ao; Qiurong Ruan; Guoping Wang
Journal:  Diagn Pathol       Date:  2017-12-19       Impact factor: 2.644

10.  Deterministic Evolutionary Trajectories Influence Primary Tumor Growth: TRACERx Renal.

Authors:  Samra Turajlic; Hang Xu; Kevin Litchfield; Andrew Rowan; Stuart Horswell; Tim Chambers; Tim O'Brien; Jose I Lopez; Thomas B K Watkins; David Nicol; Mark Stares; Ben Challacombe; Steve Hazell; Ashish Chandra; Thomas J Mitchell; Lewis Au; Claudia Eichler-Jonsson; Faiz Jabbar; Aspasia Soultati; Simon Chowdhury; Sarah Rudman; Joanna Lynch; Archana Fernando; Gordon Stamp; Emma Nye; Aengus Stewart; Wei Xing; Jonathan C Smith; Mickael Escudero; Adam Huffman; Nik Matthews; Greg Elgar; Ben Phillimore; Marta Costa; Sharmin Begum; Sophia Ward; Max Salm; Stefan Boeing; Rosalie Fisher; Lavinia Spain; Carolina Navas; Eva Grönroos; Sebastijan Hobor; Sarkhara Sharma; Ismaeel Aurangzeb; Sharanpreet Lall; Alexander Polson; Mary Varia; Catherine Horsfield; Nicos Fotiadis; Lisa Pickering; Roland F Schwarz; Bruno Silva; Javier Herrero; Nick M Luscombe; Mariam Jamal-Hanjani; Rachel Rosenthal; Nicolai J Birkbak; Gareth A Wilson; Orsolya Pipek; Dezso Ribli; Marcin Krzystanek; Istvan Csabai; Zoltan Szallasi; Martin Gore; Nicholas McGranahan; Peter Van Loo; Peter Campbell; James Larkin; Charles Swanton
Journal:  Cell       Date:  2018-04-12       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.